The Vascular and Metabolic Effects of Sunitinib in Patients With Metastatic Renal Cell Carcinoma.
Phase of Trial: Phase IV
Latest Information Update: 03 Nov 2015
At a glance
- Drugs Sunitinib (Primary)
- Indications Renal cell carcinoma
- Focus Pharmacodynamics
- Acronyms SUMAVA
- 08 Oct 2015 Results published in the British Journal of Clinical Pharmacology
- 10 Aug 2011 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 01 Nov 2010 New trial record